Carolyn Walch Slayman PhD
Sterling Professor of Genetics and Professor of Cellular and Molecular Physiology; Deputy Dean for Academic & Scientific Affairs
Research Interests
Genetics of Ion Transport
Research Summary
Research in Carolyn Slayman’s laboratory uses the plasma-membrane H+-ATPase of yeast (Saccharomyces cerevisiae) as a simple model for studies on P-type cation pumps, a physiologically important family that includes the Na+,K+-, H+,K+-, and Ca2+-ATPases of animal cells. These pumps control the ionic composition of cells; many of them also serve as important drug targets (e.g., for cardiac glycosides in the case of Na+,K+-ATPase and anti-ulcer drugs in the case of gastric H+,K+-ATPase).
Extensive Research Description
Over the past several years, the Slayman laboratory has constructed a large collection of site-directed mutants and used them to explore structure-function relationships in key regions of the 100 kDa H+-ATPase. Results of particular significance include: (1) discovery of a 13-amino acid stretch in stalk segment 4 within which mutations disrupt the interaction between the catalytic domain of the ATPase (located in the cytoplasm) and the proton channel (embedded in the membrane); and (2) clear implication of one face of stalk segment 5 in the metabolic activation of the ATPase by glucose. Cysteine residues have now been introduced into both regions, and methods are being developed to track conformational changes by means of fluorescent sulfhydryl reagents. With a recently published high resolution structure of sarcoplasmic reticulum Ca2+-ATPase as a template, biophysical data from the H+-ATPase mutants should yield helpful insights into the molecular mechanism by which ATP hydrolysis is coupled to cation transport.
In parallel, the H+-ATPase is being used as a tool to probe the way in which newly synthesized plasma membrane proteins are delivered from the endoplasmic reticulum to the cell surface, as well as the quality control mechanisms that remove poorly folded or otherwise defective proteins. During the past year, a nested series of truncations has been constructed and has provided intriguing evidence for an oligomerization step at the C-terminus of the ATPase; oligomerization appears to occur early in the secretory pathway and to be essential for normal biogenesis.
Selected Publications
- Lecchi, S., Nelson, C.J., Allen, K.E., Swaney, D.L., Thompson, K.L., Coon, J.J., Sussman, M.R., and Slayman, C.W. (2007) Tandem phosphorylation of Ser-911 and Thr-912 at the C-terminus of yeast plasma membrane H+-ATPase leads to glucose-dependent activation. J.Biol.Chem. 282:35471-35481. (PMID: 17932035)
- Guerra, G., Petrov, V.V., Allen, K.E., Miranda, M., Pardo, J.P., and Slayman, C.W. (2007) Role of transmembrane segment M8 in the biogenesis and function of yeast plasma-membrane H+-ATPase. Biochim.Biophys.Acta 1768:2383-2392. (PMID: 17573037)
- Mason, A. B., Allen, K. E., and Slayman, C. W. (2006) Effects of C-terminal truncations on trafficking of the yeast plasma membrane H+-ATPase. Biological Chemistry 281:23887-23898
- Lecchi, S., Allen, K. E., Pardo, J. P., Mason, A. B., and Slayman, C. W. (2005) Conformational changes of yeast plasma membrane H+-ATPase during activation by glucose: role of Thr912 in the carboxy-terminal tail. Biochemistry 44:16624-16632
Articles

Autumn 2011
Pioneer in genetic engineering and biotech wins Parker Medal
In the early 1960s, a doctoral student at the University of Pittsburgh wrote to Edward A. Adelberg, Ph.D. ’49, chair of...

Winter 2007
New funding paradigms reshape research
Flat funding and a new research paradigm have turned federal funding of medical research on its head. After the recent...

Spring 2005
The molecule meets the computer chip
It is difficult to imagine two places more different than The Eagle Pub and Celera Genomics, each of which provided the...

Autumn 2003
In the dean’s office, it takes a brain surgeon
On a Monday afternoon in late June, close to a hundred senior faculty members filled the Historical Library to witness...
Autumn 2009
A new ARRA for science as stimulus package boosts NIH grants around the country
In his inaugural address in January, President Barack Obama pledged to “restore science to its rightful place” and “not...
Winter 1999
Perfecting the Faculty Practice
David J. Leffell, M.D., medical director of the Yale Faculty Practice for the past three years and a professor of...

Autumn 2005
Fund honors a mentor, boosts young scientists
When Applera Corp. of Norwalk, Conn., asked members of its board of directors last spring to suggest recipients for...
Fall 2000 | Winter 2001
Six professors named to endowed professorships
University President Richard C. Levin, Ph.D., has named six members of the medical school faculty to endowed...
Summer 1998
Carolyn W. Slayman, Ph.D.
Carolyn W. Slayman, Ph.D., Sterling Professor of Genetics and Cellular and Molecular Physiology and deputy dean for...

Autumn 2003
Building a better drug
The rational approach to drug discovery is changing pharmacology, but serendipity and imagination still play a starring...

Spring 2009
How a rock 'n' roll scientist built a better mouse
By inserting human genes into mice, Richard Flavell and his team are creating a mouse with a working human immune...

Autumn 2008
Is the straight road too narrow?
Demands for cures and a flat NIH budget are putting pressure on scientists to produce findings that go right to the...

Winter 2003
The big move
Relocating 91 laboratories, a magnetic resonance center and the medical school’s teaching facilities across Congress...
Fall 1998
Found in translation
A cell is a cell is a cell, researchers say, as Drosophila, yeast and other model organisms yield clues to human...

Autumn 2011
Is the physician-scientist an endangered species?
One of the challenges of interviewing Danny Balkin is that he keeps asking the questions—about the writing process, the...

Spring 2002
The toll road
In science, an idea can lie dormant for a century and then enjoy a fantastic rebirth. That’s what happened when Charlie...

Autumn 2005
A year at the helm
Since he arrived at Yale in 2004, Dean Robert Alpern has led faculty to a new vision of the medical school, with a...
Summer 1998
Budget, space concerns addressed in school's strategic facilities plan
When David A. Kessler, M.D., began speaking with faculty and top administrators in early 1997 before coming to the...




